Photo by sarahdorweiler from unsplash
Tenofovir alafenamide (TAF) is approved for paediatric use in fixed‐dose combination tablets, but efficacy and safety data in children are limited. We conducted a systematic review on the efficacy/effectiveness and… Click to show full abstract
Tenofovir alafenamide (TAF) is approved for paediatric use in fixed‐dose combination tablets, but efficacy and safety data in children are limited. We conducted a systematic review on the efficacy/effectiveness and safety of TAF in infants, children and adolescents living with HIV.
Keywords:
safety;
systematic review;
adolescents living;
effectiveness safety;
children adolescents;
tenofovir alafenamide
Journal Title: Journal of the International AIDS Society
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the International AIDS Society
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!